China Sacroiliitis Treatment Market: How Is Physical Therapy and Rehabilitation Integrated Into Chinese AS Care?
Chinese domestic biopharmaceutical companies have become significant competitors in the AS biologic treatment market, with the China Sacroiliitis Treatment Market reflecting the development and commercialization of domestic adalimumab biosimilars, anti-IL-17A antibodies, and JAK inhibitors by Chinese companies that are progressively capturing market share from international originator products...
0 Commenti 0 condivisioni 30 Views 0 Anteprima